BGM (BGM Group) Institutional Ownership : 0.01% (As of Apr. 23, 2025)

View and export this data going back to 2021. Start your Free Trial

What is BGM Group Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, BGM Group's institutional ownership is 0.01%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, BGM Group's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, BGM Group's Float Percentage Of Total Shares Outstanding is 4.32%.

BGM Group Institutional Ownership Historical Data

The historical data trend for BGM Group's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BGM Group Institutional Ownership Chart

BGM Group Historical Data

The historical data trend for BGM Group can be seen below:

	2024-04-30	2024-05-31	2024-06-30	2024-07-31	2024-08-31	2024-09-30	2024-10-31	2024-11-30	2024-12-31	2025-03-31
Institutional Ownership	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.02	0.02	0.07

BGM Group Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

BGM Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BGM Group Ltd (NAS:BGM) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 152 Hongliang East 1st Street No. 1703, Tianfu New District, Chengdu, CHN, 610200

Website

https://www.bgmgroupltd.com

BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.